ZEB1 and metastatic malignant neoplasm in the lymph nodes: We found that ZEB1‐AS1 levels in ESCC patients with III + IV staging and lymph node metastasis were markedly higher than those with I + II staging and without lymph node metastasis (Figure 3A,B), and similar results were found in ZEB1 expression pattern (Figure 3C,D).